Middle East and Africa Dietary Supplements Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Vitamins, Minerals, Proteins and Amino Acids, Probiotics, Blends, and Others), Form (Tablets, Capsules and Softgels, Powders, and Others),

Middle East and Africa Dietary Supplements Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Vitamins, Minerals, Proteins and Amino Acids, Probiotics, Blends, and Others), Form (Tablets, Capsules and Softgels, Powders, and Others), and Distribution Channel (Supermarkets and Hypermarkets, Specialty Stores, Online Retail, and Others)

The MEA dietary supplements market is expected to grow from US$ 9,551.77 million in 2021 to US$ 14,646.02 million by 2028; it is estimated to grow at a CAGR of 6.3% from 2021 to 2028. The vegan population has reported a constant increase over the past few years. Further, preventing the exploitation of animals and the environment is a major concern of people shifting to a vegan diet, thereby increasing the demand for plant-based dietary supplements. This is likely to change customers’ preferences toward plant-based herbal supplements and botanicals, offering even more potential for the growth of herbal supplements in the dietary supplements sector. Further, consumer preferences are shifting toward botanical extracts due to their increasing desire for clean-label products, rising concerns about sustainability, and an urgent need to avoid allergens. The demographic for these herbal supplements is transitioning from vegans to flexitarians, indicating changes in customer inclinations. The changing consumer perception that plant-based products are safer and healthier than animal-derived products is driving the demand for plant-based dietary supplements. The growing trend of veganism is driving manufacturers to launch new products. Thus, the rising preference for plant-based herbal supplements is giving rise to several key trends, thereby influencing the growth of the MEA dietary supplements market.

In the MEA region, Turkey, South Africa, Iraq, and Israel are among the major countries with a large number of COVID-19 confirmed cases and deaths. According to the International Finance Corporation, the COVID-19 pandemic has a severe impact on the economy of the MEA, which has led to declining oil production, tourism, and remittances. The quarantine measures implemented for sanitary purposes in the region have led to a standstill of several activities across diverse economic sectors. The MEA region comprises many growing economies, which are prospective markets for dietary supplements vendors. However, the pandemic has significantly increased the growth of the dietary supplements market in the region due to various health benefits associated with it that help in improving the immune system.

Based on type, the probiotics segment is expected to be the fastest-growing segment during the forecast period in the market. Probiotics are microorganisms, such as yeast and bacteria, which aid in maintaining gut microbial balance in humans and animals. Probiotics components boost the body's natural digestive juices and enzymes to promote optimal digestive system function. Probiotic dietary supplements have grown popularity among consumers looking for natural remedies for various health problems. As opposed to pharmaceuticals, probiotics are a natural approach used to prevent various disorders connected to gut health, gastrointestinal conditions, and immune building. The development of innovative delivery systems, including powders, capsules, gummies, and chewable products, is driving the segment's growth. Furthermore, the unexpected impact of COVID-19 has created a need for products that improve immunological health, thereby increasing the demand for probiotic supplements.

The overall MEA dietary supplements market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the MEA dietary supplements market. The process also serves the purpose of obtaining overview and forecast for the MEA dietary supplements market with respects to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, and to gain more analytical insights into the topic. The participants who typically take part in such a process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the MEA dietary supplements market. Abbott; Abbott; Amway Corp.; Bayer AG; Bionova; GlaxoSmithKline plc.; Otsuka Holdings Co., Ltd; Pfizer Inc.; and The Bountiful Company are among a few players operating in the MEA dietary supplements market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA dietary supplements market.    
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA dietary supplements market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the dietary supplements market, as well as those hindering it   
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution